http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014105983-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0d51806567d8f1e090d1507c5f6dd3a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f5f6ce38380e5a2b913a4ac3c1f1bad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc0fd8d1d8a7fbdc003ac287825b7822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e56162e5ae7c67b987a8a16e2bb2e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1df1d692e07be1b853c6dd17df4b1f02
publicationDate 2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014105983-A1
titleOfInvention Pulmonary Delivery for Levodopa
abstract In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.
priorityDate 2002-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001018916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0072827-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6514482-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7556798-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54322067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129349966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23617285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129630477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128684764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129335251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129281774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127958258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160545214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128302317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159281599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452234505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450454168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129120409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859

Total number of triples: 55.